Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia-Reference-Cited by-同舟云学术

Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia

Published:2013-08-22 Issue:12 Volume:15 Page:1154-1160
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Rosenstock J.¹,Seman L. J.²,Jelaska A.²,Hantel S.³,Pinnetti S.³,Hach T.⁴,Woerle H. J.⁴

Affiliation:

1. Dallas Diabetes and Endocrine Center at Medical City; Dallas TX USA

2. Boehringer Ingelheim Pharmaceuticals, Inc.; Ridgefield CT USA

3. Boehringer Ingelheim GmbH & Co. KG; Biberach Germany

4. Boehringer Ingelheim GmbH & Co. KG; Ingelheim Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12185/fullpdf

Reference23 articles.

1. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going;DeFronzo;Am J Med,2010

2. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006;Cheung;Am J Med,2009

3. An overview of management issues in adult patients with type 2 diabetes mellitus;Vigersky;J Diabetes Sci Technol,2011

4. Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis;Schernthaner;Diabetologia,2010

5. Glucose handling by the kidney;Mather;Kidney Int,2011

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2i effect on atrial fibrillation: A network meta‐analysis of randomized controlled trials;Journal of Cardiovascular Electrophysiology;2024-06-28

2. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21

3. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review;Frontiers in Endocrinology;2023-12-19

4. Sodium–glucose co-transporter-2 inhibitors for the prevention of atrial fibrillation: a systemic review and meta-analysis;European Journal of Preventive Cardiology;2023-11-15

5. Adverse effects of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis;Heart Failure Reviews;2023-11-02